Search Results - "Halsall, P. Jane"

Store-operated Ca2+ Entry in Malignant Hyperthermia-susceptible Human Skeletal Muscle by Duke, Adrian M., Hopkins, Philip M., Calaghan, Sarah C., Halsall, Jane P., Steele, Derek S.

“…In malignant hyperthermia (MH), mutations in RyR1 underlie direct activation of the channel by volatile anesthetics, leading to muscle contracture and a…”
Get full text

The role of CACNA1S in predisposition to malignant hyperthermia by Carpenter, Danielle, Ringrose, Christopher, Leo, Vincenzo, Morris, Andrew, Robinson, Rachel L, Halsall, P Jane, Hopkins, Philip M, Shaw, Marie-Anne

“…Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder of skeletal muscle, characterised by an elevated calcium release from the skeletal muscle…”
Get full text

A RYR1 mutation associated with recessive congenital myopathy and dominant malignant hyperthermia in Asian families by Carpenter, Danielle, Ismail, Azzam, Robinson, Rachel L., Ringrose, Christopher, Booms, Patrick, Iles, David E., Halsall, P. Jane, Steele, Derek, Shaw, Marie-Anne, Hopkins, Philip M.

“…In this study we present 3 families with malignant hyperthermia (MH), all of Indian subcontinent descent. One individual from each of these families was fully…”
Get full text

RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes by Robinson, Rachel L., Brooks, Collin, Brown, Sarah L., Ellis, F. Richard, Halsall, P. Jane, Quinnell, Rupert J., Shaw, Marie-Anne, Hopkins, Philip M.

“…Malignant hyperthermia (MH) and central core disease (CCD) are autosomal dominant disorders of skeletal muscle. Susceptibility to MH is only apparent after…”
Get full text

Mutation analysis of two patients with hypokalemic periodic paralysis and suspected malignant hyperthermia by Marchant, Clare L., Ellis, F. Richard, Halsall, P. Jane, Hopkins, Philip M., Robinson, Rachel L.

“…Hypokalemic periodic paralysis (HypoPP) and malignant hyperthermia (MH) are autosomal‐dominant genetically heterogeneous ion channelopathies. MH has been…”
Get full text

The role of CACNA1Sin predisposition to malignant hyperthermia by Carpenter, Danielle, Ringrose, Christopher, Leo, Vincenzo, Morris, Andrew, Robinson, Rachel L, Halsall, P Jane, Hopkins, Philip M, Shaw, Marie-Anne

Get full text

An Analysis of the Predictive Probability of the In Vitro Contracture Test for Determining Susceptibility to Malignant Hyperthermia by Hopkins, Philip M., Ellis, F. Richard, Halsall, P. Jane, Stewart, Alistair D.

Get full text

An Analysis of the Predictive Probability of the In Vitro Contracture Test for Determining Susceptibility to Malignant Hyperthermia by Hopkins, Philip M., Ellis, F. Richard, Halsall, P. Jane, Stewart, Alistair D.

“…An objective estimate of the likelihood of correct designation of malignant hyperthermia (MH) susceptibility from in vitro contracture test (IVCT) results is…”
Get full text

Malignant hyperthermia by Halsall, P Jane, Hopkins, Philip M

Get full text

No C1840 to T mutation in RYR1 in malignant hyperthermia by Hall-Curran, J L, Stewart, A D, Ball, S P, Halsall, J P, Hopkins, P M, Ellis, F R

Get more information

Susceptibility to malignant hyperpyrexia by Ellis, F R, Halsall, P J

Get more information